<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Di Dona G</submitter><funding>Fondazione Regionale per la Ricerca Biomedica</funding><funding>Ministero dell'Istruzione, dell'Università e della Ricerca</funding><funding>Ministero dell’Istruzione, dell’Università e della Ricerca</funding><pagination>11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12947359</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>Developmental dyslexia (DD) affects approximately 10% of individuals, impairing reading ability thus limiting professional fulfilment and psychological wellbeing. DD is associated with both phonological and visual deficits, and the latter are attributed to dysfunctions of the magnocellular-dorsal visual stream, which has a critical role in planning saccades and supporting the extraction of letters/words identity. Currently, there are no effective treatments to restore the brain networks underlying visuospatial analysis and oculomotor efficiency. Adults with DD were enrolled in a randomised clinical trial introducing a non-invasive neuromodulation protocol specifically designed to enhance dorsal stream functionality. We used bi-focal beta-band transcranial alternating current stimulation (t</pubmed_abstract><journal>Journal of neurodevelopmental disorders</journal><pubmed_title>A new effective treatment for dyslexia based on dorsal visual stream neuromodulation.</pubmed_title><pmcid>PMC12947359</pmcid><funding_grant_id>1751150</funding_grant_id><funding_grant_id>2022H4ZRSN</funding_grant_id><pubmed_authors>Venniro L</pubmed_authors><pubmed_authors>De Benedetto F</pubmed_authors><pubmed_authors>Turri C</pubmed_authors><pubmed_authors>Perani D</pubmed_authors><pubmed_authors>Di Dona G</pubmed_authors><pubmed_authors>Zamfira DA</pubmed_authors><pubmed_authors>Ronconi L</pubmed_authors><pubmed_authors>Venturini C</pubmed_authors></additional><is_claimable>false</is_claimable><name>A new effective treatment for dyslexia based on dorsal visual stream neuromodulation.</name><description>Developmental dyslexia (DD) affects approximately 10% of individuals, impairing reading ability thus limiting professional fulfilment and psychological wellbeing. DD is associated with both phonological and visual deficits, and the latter are attributed to dysfunctions of the magnocellular-dorsal visual stream, which has a critical role in planning saccades and supporting the extraction of letters/words identity. Currently, there are no effective treatments to restore the brain networks underlying visuospatial analysis and oculomotor efficiency. Adults with DD were enrolled in a randomised clinical trial introducing a non-invasive neuromodulation protocol specifically designed to enhance dorsal stream functionality. We used bi-focal beta-band transcranial alternating current stimulation (t</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T22:23:18.499Z</modification><creation>2026-07-13T03:07:16.467Z</creation></dates><accession>S-EPMC12947359</accession><cross_references><pubmed>41620638</pubmed><doi>10.1186/s11689-026-09675-3</doi></cross_references></HashMap>